To What Extent Can Preventive Treatments Prevent Damage From Systemic Lupus Erythematosus?
暂无分享,去创建一个
[1] D. Gladman,et al. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus , 2011, Arthritis care & research.
[2] Susana Gordo,et al. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage , 2010, Arthritis care & research.
[3] R. Telles,et al. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics , 2010, Lupus.
[4] M. Petri,et al. Development and initial validation of a self‐assessed lupus organ damage instrument , 2010, Arthritis care & research.
[5] J. Reveille,et al. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort , 2010, Arthritis care & research.
[6] C. Pineau,et al. Cigarette Smoking and Cutaneous Damage in Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.
[7] J. Reveille,et al. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX) , 2009, Lupus.
[8] J. Reveille,et al. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort , 2009, Lupus.
[9] D. Isenberg,et al. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. , 2009, Rheumatology.
[10] M. Hernán,et al. Prednisone, Lupus Activity, and Permanent Organ Damage , 2009, The Journal of Rheumatology.
[11] M. García-Carrasco,et al. Risk factors of vertebral fractures in women with systemic lupus erythematosus , 2009, Clinical Rheumatology.
[12] V. Werth,et al. The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. , 2009, Autoimmunity reviews.
[13] J. Reveille,et al. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. , 2008, Rheumatology.
[14] M. Abrahamowicz,et al. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. , 2008, Arthritis and rheumatism.
[15] J. Reveille,et al. Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA): LXI. Value of C-Reactive Protein as a Marker of Disease Activity and Damage , 2008, The Journal of Rheumatology.
[16] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[17] M. Petri,et al. High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. , 2008, Seminars in arthritis and rheumatism.
[18] M. Petri,et al. Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort , 2008, Lupus.
[19] J. Reveille,et al. Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII) , 2008, Annals of the rheumatic diseases.
[20] J. Reveille,et al. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV) , 2007, Annals of the rheumatic diseases.
[21] M. Petri,et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. , 2007, Arthritis and rheumatism.
[22] C. Ohlsson,et al. Prevalence and risk factors of osteoporosis in female SLE patients-extended report. , 2007, Rheumatology.
[23] D. Symmons,et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.